MedPath

A clinical study to evaluate the influence of strength of satva in Pulmonary Tuberculosis patients

Not yet recruiting
Conditions
Tuberculosis of lung,
Registration Number
CTRI/2022/04/041912
Lead Sponsor
Institute of Medical Science Banaras Hindu University Varanasi Uttar Pradesh India
Brief Summary

This study is a single group prospective observational study to evaluate the strength of satva and its role in Pulmonary Tuberculosis. The primary outcome will association of the type of Satva and its role in response to the treatment of Pulmonary Tuberculosis. The secondary outcome will be the association of types of Satva with adverse reactions and complications of Pulmonary Tuberculosis.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
75
Inclusion Criteria

1.Confirmed pulmonary tuberculosis patients irrespective of gender 2.Patients with well controlled comorbid conditions 3.Age group between 18-70 years.

Exclusion Criteria
  • 1.Not willing to complete the consent process as describe in proforma.
  • 2.Inability to comply with study procedures and methods.
  • 3.HIV patients.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the type of Satva and its role in response to the treatment of Pulmonary Tuberculosis.1.5yr
Secondary Outcome Measures
NameTimeMethod
To evaluate the association of types of Satva with adverse reactions and complications of Pulmonary Tuberculosis.1.5 yr

Trial Locations

Locations (1)

Sir Sunderlal Hospital

🇮🇳

Varanasi, UTTAR PRADESH, India

Sir Sunderlal Hospital
🇮🇳Varanasi, UTTAR PRADESH, India
ARUNIMA P S
Principal investigator
7356259443
arunimaps888@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.